{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:05:37Z","timestamp":1774076737940,"version":"3.50.1"},"reference-count":29,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,3,18]]},"DOI":"10.1248\/bpb.b25-00706","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:08:06Z","timestamp":1773785286000},"page":"513-519","source":"Crossref","is-referenced-by-count":0,"title":["Role of P-Glycoprotein Expression and Scaffold Proteins in the Entire Metastasis Process in Lung Cancer Cell Lines"],"prefix":"10.1248","volume":"49","author":[{"given":"Wangyang","family":"Liu","sequence":"first","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Takasaki University of Health and Welfare, 60 Nakaorui-machi, Takasaki, Gunma 370\u20130033, Japan"},{"name":"School of Medical Imaging, Xuzhou Medical University, No.209 Tongshan Road, Xuzhou, Jiangsu 221004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mana","family":"Yajima","sequence":"additional","affiliation":[{"name":"Kendai Translational Research Center, 450\u20131\u2013A Hidaka-machi, Takasaki, Gunma 370\u20130002, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyoshi","family":"Hariba","sequence":"additional","affiliation":[{"name":"Graduate School of Medical Sciences, Kanazawa University, 13\u20131 Takara-machi, Kanazawa, Ishikawa 920\u20138640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Sunakawa","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Takasaki University of Health and Welfare, 60 Nakaorui-machi, Takasaki, Gunma 370\u20130033, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Yano","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Science, Yokohama University of Pharmacy, 601 Matano-cho, Totsuka-ku, Yokohama 245\u20130066, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Mizoi","sequence":"additional","affiliation":[{"name":"School of Pharmacy, International University of Health and Welfare, 2600\u20131 Kitakanemaru, Otawara, Tochigi 324\u20138501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Ogihara","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Takasaki University of Health and Welfare, 60 Nakaorui-machi, Takasaki, Gunma 370\u20130033, Japan"},{"name":"Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278\u20138510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. <i>CA Cancer J. Clin.<\/i>, <b>74<\/b>, 229\u2013263 (2024).","DOI":"10.3322\/caac.21834"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, <i>2012. CA Cancer J. Clin.<\/i>, <b>65<\/b>, 87\u2013108 (2015).","DOI":"10.3322\/caac.21262"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Alexander M, Kim SY, Cheng H. Update 2020: management of non-small cell lung cancer. <i>Lung<\/i>, <b>198<\/b>, 897\u2013907 (2020).","DOI":"10.1007\/s00408-020-00407-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Rocco D, Della Gravara L, Battiloro C, Gridelli C. The role of nivolumab combined to immunotherapy and\/or chemotherapy in the first-line treatment of advanced Non Small Cell Lung Cancer. <i>Expert Opin. Biol. Ther.<\/i>, <b>21<\/b>, 303\u2013309 (2021).","DOI":"10.1080\/14712598.2021.1869209"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Wan J, Ling XA, Wang J, Ding GG, Wang X. Inhibitory effect of Ubenimex combined with fluorouracil on multiple drug resistance and P-glycoprotein expression level in non-small lung cancer. <i>J. Cell. Mol. Med.<\/i>, <b>24<\/b>, 12840\u201312847 (2020).","DOI":"10.1111\/jcmm.15875"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Zhang YK, Wang YJ, Gupta P, Chen ZS. Multidrug resistance proteins (MRPs) and cancer therapy. <i>AAPS J.<\/i>, <b>17<\/b>, 802\u2013812 (2015).","DOI":"10.1208\/s12248-015-9757-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Bukowski K, Kciuk M, Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy. <i>Int. J. Mol. Sci.<\/i>, <b>21<\/b>, 3233 (2020).","DOI":"10.3390\/ijms21093233"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Huang J, Ecker GF. A structure-based view on ABC-transporter linked to multidrug resistance. <i>Molecules<\/i>, <b>28<\/b>, 495 (2023).","DOI":"10.3390\/molecules28020495"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Gon\u00e7alves BMF, Cardoso DSP, Ferreira MJU. Overcoming multidrug resistance: flavonoid and terpenoid nitrogen-containing derivatives as ABC transporter modulators. <i>Molecules<\/i>, <b>25<\/b>, 3364 (2020).","DOI":"10.3390\/molecules25153364"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ogihara T, Mizoi K, Kamioka H, Yano K. Physiological roles of ERM proteins and transcriptional regulators in supporting membrane expression of efflux transporters as factors of drug resistance in cancer. <i>Cancers<\/i>, <b>12<\/b>, 3352 (2020).","DOI":"10.3390\/cancers12113352"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Yano K, Okabe C, Fujii K, Kato Y, Ogihara T. Regulation of breast cancer resistance protein and P-glycoprotein by ezrin, radixin and moesin in lung, intestinal and renal cancer cell lines. <i>J. Pharm. Pharmacol.<\/i>, <b>72<\/b>, 575\u2013582 (2020).","DOI":"10.1111\/jphp.13225"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Wang W, Soroka CJ, Mennone A, Rahner C, Harry K, Pypaert M, Boyer JL. Radixin is required to maintain apical canalicular membrane structure and function in rat hepatocytes. <i>Gastroenterology<\/i>, <b>131<\/b>, 878\u2013884 (2006).","DOI":"10.1053\/j.gastro.2006.06.013"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Guo F, Parker Kerrigan BC, Yang D, Hu L, Shmulevich I, Sood AK, Xue F, Zhang W. Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions. <i>J. Hematol. Oncol.<\/i>, <b>7<\/b>, 19 (2014).","DOI":"10.1186\/1756-8722-7-19"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Gurzu S, Turdean S, Kovecsi A, Contac AO, Jung I. Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: an update. <i>World J. Clin. Cases<\/i>, <b>3<\/b>, 393\u2013404 (2015).","DOI":"10.12998\/wjcc.v3.i5.393"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Batlle E, Sancho E, Franc\u00ed C, Dom\u00ednguez D, Monfar M, Baulida J, Garc\u00eda de Herreros A. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. <i>Nat. Cell Biol.<\/i>, <b>2<\/b>, 84\u201389 (2000).","DOI":"10.1038\/35000034"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Pan G, Liu Y, Shang L, Zhou F, Yang S. EMT-associated microRNAs and their roles in cancer stemness and drug resistance. <i>Cancer Commun.<\/i>, <b>41<\/b>, 199\u2013217 (2021).","DOI":"10.1002\/cac2.12138"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Gote V, Nookala AR, Bolla PK, Pal D. Drug resistance in metastatic breast cancer: tumor targeted nanomedicine to the rescue. <i>Int. J. Mol. Sci.<\/i>, <b>22<\/b>, 4673 (2021).","DOI":"10.3390\/ijms22094673"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kamioka H, Tomono T, Fujita A, Onozato R, Iijima M, Tsuchida S, Arai T, Fujita Y, Zhang X, Yano K, Ogihara T. Moesin-mediated P-glycoprotein activation during snail-induced epithelial-mesenchymal transition in lung cancer cells. <i>J. Pharm. Sci.<\/i>, <b>109<\/b>, 2302\u20132308 (2020).","DOI":"10.1016\/j.xphs.2020.03.008"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Liu W, Zhang X, Sunakawa H, Perera LMB, Martha L, Mizoi K, Ogihara T. Mechanism of induction of P-gp activity during MET induced by DEX in lung cancer cell line. <i>J. Pharm. Sci.<\/i>, <b>113<\/b>, 1674\u20131681 (2024).","DOI":"10.1016\/j.xphs.2024.02.027"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Tomono T, Yano K, Ogihara T. Snail-induced epithelial-to-mesenchymal transition enhances P-gp-mediated multidrug resistance in HCC827 cells. <i>J. Pharm. Sci.<\/i>, <b>106<\/b>, 2642\u20132649 (2017).","DOI":"10.1016\/j.xphs.2017.03.011"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Wei Z, Babkirk K, Chen S, Pei M. Epithelial-to-mesenchymal transition transcription factors: new strategies for mesenchymal tissue regeneration. <i>Cytokine Growth Factor Rev.<\/i>, <b>83<\/b>, 99\u2013124 (2025).","DOI":"10.1016\/j.cytogfr.2025.02.001"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Vincan E, Brabletz T, Faux MC, Ramsay RG. A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis. <i>Cells Tissues Organs<\/i>, <b>185<\/b>, 20\u201328 (2007).","DOI":"10.1159\/000101299"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Forte E, Chimenti I, Rosa P, Angelini F, Pagano F, Calogero A, Giacomello A, Messina E. EMT\/MET at the crossroad of stemness, regeneration and oncogenesis: the Ying-Yang equilibrium recapitulated in cell spheroids. <i>Cancers<\/i>, <b>9<\/b>, 98 (2017).","DOI":"10.3390\/cancers9080098"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Miletti-Gonz\u00e1lez KE, Chen S, Muthukumaran N, Saglimbeni GN, Wu X, Yang J, Apolito K, Shih WJ, Hait WN, Rodr\u00edguez-Rodr\u00edguez L. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. <i>Cancer Res.<\/i>, <b>65<\/b>, 6660\u20136667 (2005).","DOI":"10.1158\/0008-5472.CAN-04-3478"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Pokharel D, Padula MP, Lu JF, Jaiswal R, Djordjevic SP, Bebawy M. The role of CD44 and ERM proteins in expression and functionality of P-glycoprotein in breast cancer cells. <i>Molecules<\/i>, <b>21<\/b>, 290 (2016).","DOI":"10.3390\/molecules21030290"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Huo Q, Li K, Sun X, Zhuang A, Minami K, Tamari K, Ogawa K, Fishel ML, Li BY, Yokota H. The inhibition of pancreatic cancer progression by K-Ras-overexpressing mesenchymal stem cell-derived secretomes. <i>Sci. Rep.<\/i>, <b>13<\/b>, 15036 (2023).","DOI":"10.1038\/s41598-023-41835-6"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kibria G, Hatakeyama H, Harashima H. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system. <i>Arch. Pharm. Res.<\/i>, <b>37<\/b>, 4\u201315 (2014).","DOI":"10.1007\/s12272-013-0276-2"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Kobori T, Fujiwara S, Miyagi K, Harada S, Nakamoto K, Nakagawa T, Takahashi H, Narita M, Tokuyama S. Involvement of moesin in the development of morphine analgesic tolerance through P-glycoprotein at the blood-brain barrier. <i>Drug Metab. Pharmacokinet.<\/i>, <b>29<\/b>, 482\u2013489 (2014).","DOI":"10.2133\/dmpk.DMPK-14-RG-042"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ponuwei GA. A glimpse of the ERM proteins. <i>J. Biomed. Sci.<\/i>, <b>23<\/b>, 35 (2016).","DOI":"10.1186\/s12929-016-0246-3"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/3\/49_b25-00706\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:46:48Z","timestamp":1774064808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/3\/49_b25-00706\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00706","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"article-number":"b25-00706"}}